Skip to main content

CORRECTION article

Front. Oncol., 04 October 2022
Sec. Cancer Genetics

Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing

Wenli MaoWenli Mao1Qingzhen Yu,Qingzhen Yu1,2Kefeng WangKefeng Wang1Qiang MaQiang Ma1Yuxin ZhengYuxin Zheng1Guojun ZhangGuojun Zhang3Wei LuoWei Luo4Nianwu WangNianwu Wang1Yukun Wang,*Yukun Wang1,5*
  • 1Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, China
  • 2Medical Research Center, Southern University of Science and Technology Hospital, Shenzhen, China
  • 3Nutrition Department, Southern University of Science and Technology Hospital, Shenzhen, China
  • 4Department of Clinical Laboratory, Southern University of Science and Technology Hospital, Shenzhen, China
  • 5Department of Pharmacy, Southern University of Science and Technology Hospital, Shenzhen, China

A corrigendum on
Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing

by Mao W, Yu Q, Wang K, Ma Q, Zheng Y, Zhang G, Luo W, Wang N and Wang Y (2022). Front. Oncol. 12:791332. doi: 10.3389/fonc.2022.791332

In the published article, there was an error in Figure 2B as published. The corrected Figure 2B and its caption “GO function and KEGG pathway enrichment of differently methylated m6A genes. (A) The top 10 GO terms of genes with down-regulated m6A peaks. (B) The top 10 GO terms of genes with up-regulated m6A peaks. (C) The top 10 KEGG pathways of genes with down-regulated m6A peaks. (D) The top 10 KEGG pathways of genes with up-regulated m6A peaks.” appear below.

FIGURE 2
www.frontiersin.org

Figure 2 GO function and KEGG pathway enrichment of differently methylated m6A genes. (A) The top 10 GO terms of genes with down-regulated m6A peaks. (B) The top 10 GO terms of genes with up-regulated m6A peaks. (C) The top 10 KEGG pathways of genes with down-regulated m6A peaks. (D) The top 10 KEGG pathways of genes with up-regulated m6A peaks.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: lung adenocarcinoma, m6A, MeRIP-seq, GPRIN1, prognosis

Citation: Mao W, Yu Q, Wang K, Ma Q, Zheng Y, Zhang G, Luo W, Wang N and Wang Y (2022) Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing. Front. Oncol. 12:1032295. doi: 10.3389/fonc.2022.1032295

Received: 23 September 2022; Accepted: 23 September 2022;
Published: 04 October 2022.

Edited and Reviewed by:

Luis Del Valle, Louisiana State University, United States

Copyright © 2022 Mao, Yu, Wang, Ma, Zheng, Zhang, Luo, Wang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yukun Wang, wangyk_sustech@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.